UiPath Hits 52-Week Low Amid AI Rivalry Fears

NEW YORK, April 28 —

UiPath, Inc. (PATH) has slid to $10.59, a 52-week low that values the robotic process automation pioneer at roughly $5.55 billion. That price tag lands on a company generating $1.61 billion in trailing revenue, 83% gross margins, and nearly half a billion dollars in free cash flow. The culprit, per multiple reports: fear that Anthropic and other AI labs are coming for UiPath's lunch.

The Anthropic Problem

The sell-off traces to a straightforward anxiety: if large language models can read documents, extract data, and trigger workflows, what exactly is UiPath's moat? Retail investors have called the reaction "irrational," and the valuation math gives that argument some weight. But the fear is not baseless. UiPath built its business automating the tedious, rule-based tasks that sit between enterprise software systems. AI agents from Anthropic, Google, and others promise to do the same thing, except with natural language instead of brittle screen-scraping scripts. The question is whether UiPath is the platform those agents run on, or the legacy tool they replace.

The Numbers That Don't Match the Price

UiPath has beaten EPS estimates in each of its three most recent reported quarters: $0.11 versus $0.10 estimated, $0.15 versus $0.08 estimated, and $0.16 versus $0.15 estimated, per its March earnings release. An 83.2% gross margin at this scale is software-elite territory. Free cash flow of $474 million on $1.61 billion in revenue means the business converts nearly 30 cents of every revenue dollar into cash. At 11.8x forward earnings, the market is pricing UiPath as though growth has already flatlined or the competitive threat has already materialized. Neither is true yet.

That disconnect between operating performance and stock price is the kind of gap that either corrects or proves prescient. Right now, the market is betting prescient.

Leadership Musical Chairs

An 8-K filed March 25 disclosed a departure or appointment of directors or principal officers, accompanied by a Regulation FD disclosure. The filing does not paint a full picture without the underlying press release details, but leadership transitions at a company already under competitive pressure tend to amplify uncertainty rather than resolve it. CEO and Chairman Daniel Dines also appeared in three Form 4 filings on March 16, each reflecting "Other" transactions involving 9,615,297 shares. The triple filing of identical share counts looks like a reclassification or trust transfer rather than a sale, but the opacity adds another layer of unease for a stock already trading at multi-year lows.

The AI Hedge

UiPath is not sitting still. On April 27, the company announced a partnership linking Databricks data with AI workflows for real-time action. Separately, reports indicate UiPath is making Google's Gemini core to its document automation platform. Both moves signal the same strategic bet: that UiPath's value lies not in the bots themselves but in the orchestration layer that connects AI models to enterprise systems. If enterprises need a platform to govern, monitor, and route AI agent activity across their tech stacks, UiPath wants to be that platform.

The logic is sound. The execution risk is enormous. Partnering with Databricks and Google means admitting that the AI brains live elsewhere. UiPath becomes the plumbing. Plumbing businesses can be very profitable, but they rarely command premium multiples.

What the Insiders Are (Not) Doing

Over the past 90 days, zero insiders made open-market purchases or sales. On April 1, four executives received equity grants: COO/CFO Ashim Gupta (306,748 shares), CTO Raghavendra Malpani (159,125 shares), General Counsel Brad Brubaker (157,208 shares), and CAO Hitesh Ramani (123,466 shares). The concurrent dispositions totaling roughly $2.13 million at $11.10 per share were all tax-withholding transactions, the automatic kind that cover the tax bill on vesting equity. Nobody chose to sell. But nobody chose to buy either, and at a 52-week low, insider buying would be the clearest signal of internal conviction. Its absence is not damning, but it is notable.

The Checkpoint

UiPath at 11.8x forward earnings with 83% gross margins and growing FCF looks like a value trap or a steal, and the answer hinges almost entirely on whether the AI competition narrative is a near-term threat or a long-term one. Near-term, the Databricks and Gemini partnerships are too fresh to evaluate. The leadership change from the March 25 filing needs more context. And the Anthropic fear, while directionally valid, has not yet shown up in UiPath's revenue trajectory or customer retention metrics. The next earnings report will be the real test: if growth holds and guidance stays firm, the 52-week low starts looking less like foresight and more like an overreaction.

Run the free UiPath, Inc. deep-dive →

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

Why is UiPath stock at a 52-week low?

UiPath shares dropped to $10.59 largely on fears that AI labs like Anthropic could commoditize the RPA automation category. As detailed above, the sell-off has compressed the forward P/E to 11.8x despite strong operating metrics.

Is UiPath profitable?

UiPath generated $474 million in trailing free cash flow on $1.61 billion in revenue with 83.2% gross margins. The company also beat EPS estimates in its three most recent quarters, as outlined in this report.

What is UiPath's Databricks partnership?

Announced April 27, 2026, the partnership links Databricks data with UiPath's AI workflows for real-time action. Per the analysis above, this is part of UiPath's strategy to position as an orchestration layer on top of AI models rather than competing with them directly.

Did UiPath insiders sell stock recently?

No insiders made open-market sales in the past 90 days. Four executives received equity grants on April 1 with roughly $2.13 million in routine tax-withholding dispositions, as detailed in the insider filing analysis above.

What is UiPath's forward P/E ratio?

UiPath trades at 11.8x forward earnings, well below the analyst consensus price target of $13.81. The report above examines why this compressed valuation may reflect genuine competitive uncertainty rather than a clear buying opportunity.